Status
Conditions
Treatments
About
Study is to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing
Full description
Post market, multi-centre, randomised, open label, multi-national, prospective study to provide evidence comparing AQUACEL® Ag+ Extra™ versus Cutimed® Sorbact® in the progression of wounds towards healing
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
205 participants in 2 patient groups
Loading...
Central trial contact
Markus Stuecker, MD; Catarina Saavedra, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal